CAR T-Cells: Refining CLL Therapy With Clinical Trials

2 Views
administrator
administrator
07/14/23

Brian Koffman, MDCM, MSEd, shares insight on his current relapse of chronic lymphocytic leukemia (CLL) and discusses the potential value of chimeric antigen receptor (CAR) T-cell therapy, which he will be receiving in an upcoming clinical trial.

View more at http://curetoday.com/

CURE: Combining science and humanity to make cancer understandable.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next